NO971519L - Fremgangsmåte for fremstilling av antigenisk forsterkede enterier og vaksiner inneholdende disse - Google Patents

Fremgangsmåte for fremstilling av antigenisk forsterkede enterier og vaksiner inneholdende disse

Info

Publication number
NO971519L
NO971519L NO971519A NO971519A NO971519L NO 971519 L NO971519 L NO 971519L NO 971519 A NO971519 A NO 971519A NO 971519 A NO971519 A NO 971519A NO 971519 L NO971519 L NO 971519L
Authority
NO
Norway
Prior art keywords
antigenically
potentiated
preparation
vaccines containing
enteric agents
Prior art date
Application number
NO971519A
Other languages
English (en)
Norwegian (no)
Other versions
NO971519D0 (no
Inventor
John L Pace
Steven M Frey
Original Assignee
Microcarb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,545 external-priority patent/US5679564A/en
Application filed by Microcarb Inc filed Critical Microcarb Inc
Publication of NO971519D0 publication Critical patent/NO971519D0/no
Publication of NO971519L publication Critical patent/NO971519L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO971519A 1994-10-05 1997-04-03 Fremgangsmåte for fremstilling av antigenisk forsterkede enterier og vaksiner inneholdende disse NO971519L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
PCT/US1995/013196 WO1996011258A1 (fr) 1994-10-05 1995-10-04 Procedes de production de bacteries enteriques antigenes ameliorees et vaccins les contenant

Publications (2)

Publication Number Publication Date
NO971519D0 NO971519D0 (no) 1997-04-03
NO971519L true NO971519L (no) 1997-05-27

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971519A NO971519L (no) 1994-10-05 1997-04-03 Fremgangsmåte for fremstilling av antigenisk forsterkede enterier og vaksiner inneholdende disse

Country Status (16)

Country Link
EP (1) EP0804542A4 (fr)
JP (1) JP3394047B2 (fr)
CN (1) CN1168693A (fr)
AU (1) AU704283B2 (fr)
BR (1) BR9509276A (fr)
CA (1) CA2202027A1 (fr)
CZ (1) CZ104397A3 (fr)
FI (1) FI971403A7 (fr)
HU (1) HUT77876A (fr)
IL (1) IL115521A0 (fr)
MX (1) MX9702431A (fr)
NO (1) NO971519L (fr)
NZ (1) NZ295907A (fr)
PL (1) PL182700B1 (fr)
SG (2) SG73509A1 (fr)
WO (1) WO1996011258A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509275A (pt) * 1994-10-05 1997-12-23 Antex Biolog Inc Processos para produzir bactéria helicobacter tendo propriedades antigênicas aumentadas testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria helicobacter e bactéria helicobacter em um animal ou amostra biológica deste produzir anticorpos antibacterianos e estimular e estimular uma imunoresposta em um animal bactéria helicobacter vacina e estojo de teste diagnóstico para detectar um hospedeiro de anticorpos para bactéria helicobacter ou para detectar bactéria helicobacter
EP1629005A2 (fr) * 2003-05-30 2006-03-01 Intercell AG Antigenes d'enterococcus
US20100074846A1 (en) * 2006-03-17 2010-03-25 Ellis John A Campylobacter Vaccines and Methods of use
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
US12403187B2 (en) 2018-12-31 2025-09-02 Bellevacc As Bacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI932248A7 (fi) * 1991-09-18 1993-07-02 Amgen Inc Sappihapposuolaa sisältävä hepatiitti B-rokotekoostumus

Also Published As

Publication number Publication date
NO971519D0 (no) 1997-04-03
SG73510A1 (en) 2000-06-20
JP3394047B2 (ja) 2003-04-07
WO1996011258A1 (fr) 1996-04-18
NZ295907A (en) 1999-04-29
FI971403A0 (fi) 1997-04-04
CZ104397A3 (cs) 1998-06-17
AU704283B2 (en) 1999-04-15
IL115521A0 (en) 1996-06-18
AU3956195A (en) 1996-05-02
CA2202027A1 (fr) 1996-04-18
FI971403L (fi) 1997-06-04
HUT77876A (hu) 1998-09-28
JPH10507347A (ja) 1998-07-21
CN1168693A (zh) 1997-12-24
PL319580A1 (en) 1997-08-18
MX9702431A (es) 1998-05-31
FI971403A7 (fi) 1997-06-04
PL182700B1 (pl) 2002-02-28
SG73509A1 (en) 2000-06-20
EP0804542A4 (fr) 1998-10-28
EP0804542A1 (fr) 1997-11-05
BR9509276A (pt) 1997-11-18

Similar Documents

Publication Publication Date Title
NO20002835L (no) 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
NO965103D0 (no) Bicykliske aromatiske forbindelser, farmasöytiske og kosmetiske preparater inneholdende disse og anvendelse derav
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO971680D0 (no) Antiskum-blanding og fremgangsmåte for fremstilling av denne
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO914665D0 (no) Fremgangsmaate til fjerning av trialkylassiner og sorpsjonsmateriale for utfoerelse av fremgangsmaaten
FI941447A0 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
EP0475023A3 (en) Curable mixtures for the preparation of epoxy-networks, method for their preparation and their application
FI955708L (fi) Menetelmä 2-fenyyli-3-aminopiperidiinin valmistamiseksi ja erottamiseksi
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
NO990520L (no) FremgangsmÕte for fremstilling av cykliske depsipeptidforbindelser og et nytt cyklisk depsipeptid
NO971519D0 (no) Fremgangsmåte for fremstilling av forsterket antigeniske enteriske bakterier og vaksiner inneholdende disse
NO975634D0 (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
NO972023D0 (no) Benzisoksasolderivater og pesticidpreparater inneholdende disse
NO304110B1 (no) FremgangsmÕte for fremstilling av glutardialdehyd
FI971402A7 (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä s isältävien rokotteiden valmistamiseksi
NO307080B1 (no) Fremgangsmåte for fremstilling av katalysatorer og anvendelse derav
FI971267A7 (fi) Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
IL117191A0 (en) Process for the preparation of oxazolidinones and their use
NO970140D0 (no) Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application